Dupixent is back on top as the pharma brand that took home the most TV impressions in May, according to data released by iSpot.tv on Thursday morning. Regeneron and Sanofi’s eczema and asthma ...
A Nektar Therapeutics drug has met the skin clearance goals of a closely watched mid-stage clinical trial in atopic dermatitis. While these preliminary results bring validation to the therapy’s novel ...
Tremfya snagged Dupixent’s place as the pharma brand with the most TV impressions in June, according to data released by iSpot.tv on Friday morning. The Johnson & Johnson brand garnered a 4.3% share ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results